Skip to main content

Respiratory Drug Delivery Market - Forecasts to 2021 - CAGR of 6.5%


According to the new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Don’t miss out on business opportunities in Pulmonary/ Respiratory Drug Delivery Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=179682410

The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis.

The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects.

The pulmonary drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.

Browse and in-depth TOC on "Pulmonary/ Respiratory Drug Delivery Market"
104 – Tables
33 - Figures
150 - Pages

The pulmonary drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.
Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators). The asthma segment accounts for the major share in the market during the forecast period due to increasing prevalence of asthma across the globe.

Request for Free Sample Report @

Currently, North America dominates the pulmonary drug delivery devices market, and Asia represents the second-largest regional market. Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region.
Prominent players in the pulmonary drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

Browse Adjacent Markets @ Medical Devices Market Research  Reports & Consulting

Comments

Popular posts from this blog

Temperature Monitoring Systems Market | 3M (US) and Omega Engineering (US) are Leading Players

Analysis of the developments in the temperature monitoring systems market from 2016 to 2018 shows that new product launches, geographic expansions, mergers & acquisitions, and contracts were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions. Some of the prominent players in the temperature monitoring systems market are 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (Subsidiary Of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), and Omega Engineering (US). The growth of this market is driven by rising manufacturing activity across a range of industries, as well as stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors). Technological advancements have introduced systems that are more efficient and capable of meeting a greater variety of needs...

Dental Bone Graft Substitutes Market | Key Market Players

The global dental bone graft substitutes market is expected to reach USD 664.3 million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as growing aging population, growing medical and dental tourism in developing countries, and increasing disposable income in developing countries across the globe are fueling the growth of this market. The major players operating in global dental bone graft substitutes market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea). The global dental bone graft substitutes market is fragmented and competitive, with a significant number of global and regional market players. This report studies the growth strategies adopted by key market players between 2013 and 2015. Leading players in the dental bone graft subst...

Cranial Fixation & Stabilization Systems Market 2019 | Top 5 Major Factors Driving Market Growth

Market Growth Factors: The increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries are the key drivers for the global cranial fixation and stabilization systems market . What Expert Analysed About The Market Growth: The global cranial fixation and stabilization systems market is expected to reach USD 1.74 billion by 2022 from USD 1.14 billion in 2017, at a CAGR of 8.7% . Market Segmentation: The cranial fixation and stabilization systems market is segmented on the basis of product, material type, end user, and region. Download FREE Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197152289 “Cranial fixation systems are expected to grow at the highest CAGR during the forecast period.” Based on product, the market is segmented into cranial fixation systems and cranial stabilization systems. The cranial fixation systems segment is expected to grow at the highest CAGR during the forecast period. The large share of th...